Equity Profile

ZBH

Zimmer Biomet Holdings, Inc.

Health CareHealth Care Equipment$18.2B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Zimmer Biomet Holdings, Inc. (ZBH) is a leading company in the health care equipment sector, specializing in orthopedic products and surgical solutions....

Key Metrics to Watch

EPS Growth

Earnings per share (EPS) growth is a key indicator of the company's profitability and operational efficiency.

Expected to be around $2.09

Revenue Performance

Revenue figures will provide insight into the overall demand for Zimmer Biomet's products and services in the current market.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ZBH Q2-2026 Earnings Preview

Context

Company Snapshot

Zimmer Biomet Holdings, Inc. (ZBH) is a leading company in the health care equipment sector, specializing in orthopedic products and surgical solutions. As the global population ages and the demand for joint replacements and surgical procedures increases, Zimmer Biomet plays a crucial role in providing innovative medical technologies.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+2.87%

Avg Stock Reaction

-3.79%

Last Quarter Recap

In Q1-2026, Zimmer Biomet reported an EPS of $2.09, exceeding expectations by 12.55%. However, the stock dropped by 10.57% the following day, indicating mixed investor sentiment despite the earnings beat.

Management Promises & Guidance

Focus on enhancing product innovation.
Commitment to improving operational efficiencies.
Plans to expand market presence in emerging regions.

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Zimmer Biomet's upcoming earnings, especially after a strong EPS surprise last quarter. However, the lack of revenue guidance raises concerns about future growth.

Bull Case

If Zimmer Biomet continues its trend of beating EPS estimates, it could signal strong operational performance and market demand, potentially leading to stock price appreciation.

Bear Case

On the other hand, if revenue growth does not meet expectations or if management provides cautious guidance, it could lead to further stock declines.

Key Metrics to Watch

EPS Growth

Expected to be around $2.09

Earnings per share (EPS) growth is a key indicator of the company's profitability and operational efficiency.

Revenue Performance

Not available

Revenue figures will provide insight into the overall demand for Zimmer Biomet's products and services in the current market.

Market Reaction

Historical average move of ±7.68%

Understanding how the market has reacted to past earnings can help gauge investor sentiment and expectations.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the revenue growth rate for the upcoming quarter?

Revenue growth is crucial for assessing the company's ability to expand its market share and meet investor expectations.

How does management plan to address operational challenges?

Understanding management's strategy for overcoming challenges can provide insights into the company's future performance and stability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Zimmer Biomet to capitalize on emerging markets, which could drive unexpected revenue growth.

Supporting Evidence

The company has a strong track record of beating EPS estimates, suggesting operational resilience.

Options pricing indicates a higher expected move than historical averages, hinting at potential surprises.

Management's focus on innovation could lead to new product launches that boost sales.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious outlook from analysts.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Zimmer Biomet can sustain its earnings growth amidst potential market challenges.

Bull Confirmed If

Earnings per share growth of at least 10% compared to the previous quarter would confirm the bull case.

Bear Confirmed If

Any revenue decline or guidance indicating lower future sales would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.66%

Historical Avg

±7.7%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±13.7% while ZBH has averaged ±7.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.8%

Calls (12K)P/C Ratio: 0.43Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zimmer Biomet beats expectations and raises guidance, history suggests the stock could rise by around 7.68% on the first day.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may experience a muted reaction.

Miss

Should the company miss earnings expectations, history suggests a potential decline of around 5.71% on the first day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Details on revenue growth in emerging markets.
3Insights into operational efficiencies and cost management.
4Management's outlook on market conditions and competition.
5Any changes in guidance or expectations for the next quarter.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Zimmer Biomet Holdings, Inc. (ZBH) is a leading company in the health care equipment sector, specializing in orthopedic products and surgical solutions....

Key Metrics to Watch

EPS Growth

Earnings per share (EPS) growth is a key indicator of the company's profitability and operational efficiency.

Expected to be around $2.09

Revenue Performance

Revenue figures will provide insight into the overall demand for Zimmer Biomet's products and services in the current market.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ZBH Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+2.87%

Avg Stock Reaction

-3.79%

Last Quarter Recap

Management Promises & Guidance

Focus on enhancing product innovation.
Commitment to improving operational efficiencies.
Plans to expand market presence in emerging regions.

Expectations

Wall Street Expectations

Bull Case

If Zimmer Biomet continues its trend of beating EPS estimates, it could signal strong operational performance and market demand, potentially leading to stock price appreciation.

Bear Case

On the other hand, if revenue growth does not meet expectations or if management provides cautious guidance, it could lead to further stock declines.

Key Metrics to Watch

EPS Growth

Expected to be around $2.09

Earnings per share (EPS) growth is a key indicator of the company's profitability and operational efficiency.

Revenue Performance

Not available

Revenue figures will provide insight into the overall demand for Zimmer Biomet's products and services in the current market.

Market Reaction

Historical average move of ±7.68%

Understanding how the market has reacted to past earnings can help gauge investor sentiment and expectations.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the revenue growth rate for the upcoming quarter?

Revenue growth is crucial for assessing the company's ability to expand its market share and meet investor expectations.

How does management plan to address operational challenges?

Understanding management's strategy for overcoming challenges can provide insights into the company's future performance and stability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Zimmer Biomet to capitalize on emerging markets, which could drive unexpected revenue growth.

Supporting Evidence

The company has a strong track record of beating EPS estimates, suggesting operational resilience.

Options pricing indicates a higher expected move than historical averages, hinting at potential surprises.

Management's focus on innovation could lead to new product launches that boost sales.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious outlook from analysts.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Zimmer Biomet can sustain its earnings growth amidst potential market challenges.

Bull Confirmed If

Earnings per share growth of at least 10% compared to the previous quarter would confirm the bull case.

Bear Confirmed If

Any revenue decline or guidance indicating lower future sales would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.66%

Historical Avg

±7.7%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±13.7% while ZBH has averaged ±7.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.8%

Calls (12K)P/C Ratio: 0.43Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zimmer Biomet beats expectations and raises guidance, history suggests the stock could rise by around 7.68% on the first day.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may experience a muted reaction.

Miss

Should the company miss earnings expectations, history suggests a potential decline of around 5.71% on the first day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Details on revenue growth in emerging markets.
3Insights into operational efficiencies and cost management.
4Management's outlook on market conditions and competition.
5Any changes in guidance or expectations for the next quarter.